Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Gelder Mark S. MD Create: Alert

All | News | Filings
Date FiledTypeDescription
03/14/2023 4 Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 62,000 options to buy @ $0.73, valued at $45.3k
Granted 20,667 restricted stock units @ $0
02/08/2023 4 Gelder Mark S. MD (CHIEF MEDICAL OFFICER) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,242 shares @ $1.36, valued at $1.7k
Exercised 5,833 restricted stock units @ $0
08/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/04/2021 4 Gelder Mark S. MD (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.
Txns: Granted 41,825 options to buy @ $5.19, valued at $217.1k
Granted 13,950 restricted stock units @ $0
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/15/2014 4 Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/
Txns: Granted 45,000 options to buy @ $9.05, valued at $407.3k
03/28/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
01/07/2014 4 Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on AP PHARMA INC /DE/
Txns: Granted 1,600,000 options to buy @ $0.45, valued at $720k
05/03/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
02/12/2013 4 Gelder Mark S. MD (SVP & Chief Medical Officer) has filed a Form 4 on AP PHARMA INC /DE/
Txns: Granted 75,000 options to buy @ $0.75, valued at $56.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy